- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Transition Therapeutics Inc
+ Add to WatchlistTTHI:US
2.9000 USD 0.0200 0.69%As of 20:10:00 ET on 05/17/2013.
Company Profile for Transition Therapeutics Inc (TTHI)
Transition Therapeutics Inc. is a biopharmaceutical company focused on developing novel therapeutics in order to address global medical needs in large disease indications, including Alzheimer's disease and diabetes.
Contact Information
Transition Therapeutics Inc
101 College Street
Suite 220
Toronto, ON M5G 1L7
Canada
Key Executives for Transition Therapeutics Inc (TTHI)
| Tony F CruzChairman/CEO | Nicole Rusaw GeorgeChief Financial Officer |
| Aleksandra PastrakVP:Clinical Dev/Medical Ofcr | Carl DamianiVP:Business Development |
| Bruce ConnopVP:Non-Clinical & Pharma Dev | Louis AlexopoulosSecretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page